Crinetics Pharmaceuticals Inc (CRNX)

May 22, 2026

Crinetics Pharmaceuticals to Participate in Jefferies Global Healthcare Conference 2026 - Yahoo Finance UK

May 22, 2026

May 22, 2026

CRNX Stock Price, Quote & Chart | CRINETICS PHARMACEUTICALS IN (NASDAQ:CRNX) - ChartMill

May 22, 2026

May 18, 2026

Hedge Fund Drops $37 Million on Rare Disease Biotech Crinetics. Is It a Buy? - The Motley Fool

May 18, 2026

May 18, 2026

Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat

May 18, 2026

May 18, 2026

Q4 2025 Crinetics Pharmaceuticals Inc Earnings Call Transcript - GuruFocus

May 18, 2026

May 17, 2026

Q3 2025 Crinetics Pharmaceuticals Inc Earnings Call Transcript - GuruFocus

May 17, 2026

May 17, 2026

Q2 2025 Crinetics Pharmaceuticals Inc Earnings Call Transcript - GuruFocus

May 17, 2026

May 17, 2026

Crinetics shares jump on robust PALSONIFY uptake and encouraging trial results - MSN

May 17, 2026

May 16, 2026

Precision Trading with Crinetics Pharmaceuticals Inc. (CRNX) Risk Zones - Stock Traders Daily

May 16, 2026

May 15, 2026

CRNX Maintained by Evercore ISI Group -- Price Target Lowered to $88 - GuruFocus

May 15, 2026

May 15, 2026

T. Rowe Price (NASDAQ: CRNX) reports 5.1% holding in Crinetics - Stock Titan

May 15, 2026

May 15, 2026

Wellington Management Group (CRNX) reports 7.79% beneficial stake in Crinetics - Stock Titan

May 15, 2026

May 15, 2026

Driehaus reduces holding in Crinetics Pharmaceuticals (NASDAQ: CRNX) to 6.11% - Stock Titan

May 15, 2026

May 15, 2026

Assessing Crinetics Pharmaceuticals (CRNX) Valuation After Q1 2026 Revenue Growth And Wider Net Loss - Sahm

May 15, 2026

May 13, 2026

Industry Analysts Just Upgraded Their Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Revenue Forecasts By 11% - Yahoo Finance

May 13, 2026

May 12, 2026

Crinetics Pharmaceuticals, Inc. 2026 Q1ResultsEarnings Call Presentation (NASDAQ:CRNX) 2026-05-12 - Seeking Alpha

May 12, 2026

May 12, 2026

Crinetics outlines plan to exceed 75% Palsonify coverage by end of Q3 2026 while funding operations into 2030 - MSN

May 12, 2026

May 12, 2026

Twilio To Rally Over 25%? Here Are 10 Top Analyst Forecasts For Monday - Sahm

May 12, 2026

May 12, 2026

What is HC Wainwright's Estimate for CRNX Q2 Earnings? - MarketBeat

May 12, 2026

May 12, 2026

Lifesci Capital Has Bullish Estimate for CRNX Q2 Earnings - MarketBeat

May 12, 2026

May 11, 2026

Earnings call transcript: Crinetics Pharma Q1 2026 revenue beats forecast - Investing.com India

May 11, 2026

May 11, 2026

Earnings call transcript: Crinetics Pharma Q1 2026 revenue beats forecast By Investing.com - Investing.com Nigeria

May 11, 2026

May 11, 2026

CRNX Maintained by Oppenheimer -- Price Target Lowered to $84.00 - GuruFocus

May 11, 2026

May 11, 2026

Oppenheimer Cuts Crinetics Pharmaceuticals (NASDAQ:CRNX) Price Target to $84.00 - MarketBeat

May 11, 2026

May 11, 2026

Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Just Reported First-Quarter Earnings And Analysts Are Lifting Their Estimates - Yahoo Finance

May 11, 2026

May 11, 2026

Oppenheimer Adjusts Crinetics Pharmaceuticals PT to $84 From $87, Maintains Outperform Rating - marketscreener.com

May 11, 2026

May 11, 2026

Oppenheimer cuts Crinetics stock price target on revenue beat By Investing.com - Investing.com Canada

May 11, 2026

May 11, 2026

HC Wainwright Has Negative Estimate for CRNX FY2030 Earnings - MarketBeat

May 11, 2026

May 09, 2026

Assessing Crinetics Pharmaceuticals (CRNX) Valuation After Recent Share Price Momentum - Yahoo Finance

May 09, 2026

May 09, 2026

Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Q1 2026 Earnings Call Transcript - Insider Monkey

May 09, 2026

May 09, 2026

Crinetics Pharmaceuticals (NASDAQ:CRNX) Lowered to "Strong Sell" Rating by Wall Street Zen - MarketBeat

May 09, 2026

May 09, 2026

Crinetics Pharmaceuticals (CRNX) Cash Burn And EPS Loss Reinforce Bearish Profitability Concerns - Sahm

May 09, 2026

May 09, 2026

Crinetics Q1 2026 slides: Palsonify launch drives 26% revenue beat By Investing.com - Investing.com South Africa

May 09, 2026

May 08, 2026

Crinetics (CRNX) Q1 2026 Earnings Transcript - AOL.com

May 08, 2026

May 08, 2026

Crinetics Pharmaceuticals Down Over 14%, on Pace for Largest Percent Decrease Since January 2025 -- Data Talk - Moomoo

May 08, 2026

May 08, 2026

CRNX Maintained by Citizens -- Price Target Lowered to $95.00 - GuruFocus

May 08, 2026

May 08, 2026

Crinetics Pharmaceuticals, Inc. (CRNX) reports Q1 loss, beats revenue estimates - MSN

May 08, 2026

May 08, 2026

Crinetics Pharmaceuticals, Inc. Q1 2026 Earnings Call Summary - Yahoo Finance

May 08, 2026

May 08, 2026

Citizens cuts Crinetics stock price target to $95 on valuation - Investing.com UK

May 08, 2026

May 08, 2026

Citizens cuts Crinetics stock price target to $95 on valuation By Investing.com - Investing.com South Africa

May 08, 2026

May 08, 2026

Crinetics (CRNX) Reports Strong Q1 Revenue Growth - GuruFocus

May 08, 2026

May 08, 2026

Crinetics Pharmaceuticals Q1 2026 Earnings Call Transcript - MarketBeat

May 08, 2026

May 08, 2026

Transcript : Crinetics Pharmaceuticals, Inc., Q1 2026 Earnings Call, May 07, 2026 - marketscreener.com

May 08, 2026

May 08, 2026

Crinetics Q1 2026 slides: Palsonify launch drives 26% revenue beat - Investing.com

May 08, 2026

May 07, 2026

Earnings call transcript: CRINETICS PHARMACEUTICALS Q1 2026 beats revenue forecasts - Investing.com Australia

May 07, 2026